Pardes Biosciences, Inc. Profile Avatar - Palmy Investing

Pardes Biosciences, Inc.

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 …

Biotechnology
US, Carlsbad [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Pardes Biosciences, Inc. has no acquisition track records yet.

M&A Deals · History

Pardes Biosciences, Inc. has no acquisition track records yet.

End of PRDS's Analysis
CIK: 1822711 CUSIP: 69945Q105 ISIN: US69945Q1058 LEI: - UEI: -
Secondary Listings
PRDS has no secondary listings inside our databases.